NCT06638567View on ClinicalTrials.gov

Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.

NARecruitingINTERVENTIONAL
Enrollment

1,008

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

September 30, 2027

Conditions
Diabetes Mellitus, Type 2Surgical Site Infection
Interventions
OTHER

Basal bolus insulin regimen

Combination of long-acting and short-acting insulin in a proactive schedule for achieving better blood glucose values postoperatively

Trial Locations (1)

Unknown

RECRUITING

Amsterdam UMC, Amsterdam

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Abraham Hulst, MD, PhD

OTHER